STOCK MARKET BSE NSE

COVID making itself antibody resistant? India already has 19 variants of coronavirus

Scientists have analysed over 2,40,000 SARS-COV-2 genome sequences from 133 countries and identified 86 with escape mutants, or variants with genetic changes that make them resistant to antibodies.

Published: 28th December 2020 01:38 AM  |   Last Updated: 28th December 2020 08:27 AM   |  A+A-

A man reacts as a health worker takes his nasal swab sample to test for COVID-19 in Jammu, India, Wednesday, Dec. 23, 2020. (Photo | AP)

Express News Service

NEW DELHI: Like elsewhere, coronavirus is quietly changing in India, making itself resistant to antibodies. As of now, 19 such variants are already present in the country, researchers associated with multiple government institutions have established.

Scientists attached with the CSIR - Institute of Genomics and Integrative Biology in Delhi, the Academy of Scientific and Innovative Research and Kurnool Medical College, Kurnool, Andhra Pradesh, analysed over 2,40,000 SARS-COV-2 genome sequences from 133 countries and identified 86 with escape mutants, or variants with genetic changes that make them resistant to antibodies.

Nineteen of these 86 variants were found in India. An escape mutation is one that allows SARS-COV-2 to evade antibodies specific to the spike protein the virus uses to enter human cells.

All vaccines are designed to generate antibodies against the spike protein to try to block the virus’ entry into cells.

The findings come at a time when the government has decided to accelerate genome sequencing to track changes in the pathogen after a variant of SARS-CoV-2 in the UK had significant structural and behavioural changes, making it 70% more infectious that the original Covid strain.

“There is no need to be alarmed but definitely a need to be cautious,” Vinod Scaria, a scientist with CSIR-IGIB and joint first author of the paper told this newspaper.

“The variations in the virus does not mean that the vaccine will not work against it but is likely to lower its efficacy,” he said.

“During the trials of the vaccine, too, it needs to be analysed whether those who are getting infected are afflicted with the variant virus,” he added.

Scaria said cases of Covid-19 re-infection should also be followed up wi th g enome sequencing.

Waking up to expedite Genome sequencing

Of the more than 1.01 crore Covid-19 positive cases reported in India, only about 6,400 samples have been genome sequenced. In contrast, the UK with 2 million cases has already sequenced 1.57 lakh samples.



Comments

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp